Viking Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

April 24, 2024

https://www.prnewswire.com/news-releases/viking-therapeutics-reports-first-quarter-2024-financial-results-and-provides-corporate-update-302126602.html

Conference call scheduled for 4:30 p.m. ET today

SAN DIEGO, April 24, 2024 /PRNewswire/ — Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced its financial results for the first quarter ended March 31, 2024, and provided an update on its clinical pipeline and other corporate developments.

Read more at prnewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.